19
Views
0
CrossRef citations to date
0
Altmetric
Review

Obesity and contraception: controversy?

, &
Pages 1-8 | Published online: 10 Jan 2012

References

  • World Health Organization (WHO). Obesity and overweight. Factsheet No 311. Geneva: WHO; 2011. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed April 3, 2011.
  • Centers for Disease Control and Prevention (CDC) Defining overweight and obesity [web page on the Internet]. Atlanta, GA: CDC; 2010 [updated June 21, 2010]. Available from: http://www.cdc.gov/obesity/defining. html#. Accessed April 3, 2011.
  • The Global Challenge of Obesity and the International Obesity Task Force: tables. Los Angeles, CA: International Union of Nutritional Sciences; nd. Available from: http://www.iuns.org/features/obesity/tabfig. htm#Figure%201. Accessed August 26, 2011.
  • CDC. Overweight and obesity: data and statistics [web page on the Internet]. Atlanta, GA: CDC; 2011 [updated May 16, 2011]. Available from: http://www.cdc.gov/obesity/data/index.html. Accessed June 8, 2011.
  • CDC. Overweight and obesity: economic consequences [web page on the Internet]. Atlanta, GA: CDC; 2011 [updated March 28, 2011]. Available from: http://www.cdc.gov/obesity/causes/economics.html. Accessed April 3, 2011.
  • National Diabetes Information Clearinghouse. National diabetes statistics, 2011: fast facts on diabetes [web page on the Internet]. Bethesda, MD: National Diabetes Information Clearinghouse; 2011. Available from: http://diabetes.niddk.nih.goV/dm/pubs/statistics/#fast. Accessed June 8, 2011.
  • Kulie T, Slattengren A, Redmer J, Counts H, Eglash A, Schrager S. Obesity and women’s health: an evidence-based review. J Am Board Fam Med. 2011;24(1):75–85.
  • Murthy AS. Obesity and contraception: emerging issues. Sem Reprod Med. 2010;28(2):156–163.
  • BD - Worldwide. Newsroom: diabetes care [web page on the Internet]. Franklin Lakes, NJ: Becton, Dickinson and Company; 2011. Available from: http://www.bd.com/press/newsroom/diabetes.asp. Accessed April 3, 2011.
  • Packinathan I, Finer N. Medical consequences of obesity. Obesity. 2003:8–12.
  • Bianchini F, Kaaks R, Vainio H. Overweight, obesity and cancer risk. Lancet Oncol. 2002;3:565–574.
  • Mansour D. Implications of the growing obesity epidemic on contraception and reproductive health. J Fam Plan Reprod Health Care. 2004;30(4):209–211.
  • Avi Dor CF. Heavy Burden Report. Washington DC: The George Washington University, School of Public Health and Health Services, Department of Health Policy; 2010. Available from: http://www.gwumc. edu/sphhs/departments/healthpolicy/pdf/HeavyBurdenReport.pdf. Accessed April 3, 2011.
  • Wuntakal R, Hollingworth T. The implications of obesity on pregnancy. Obstet Gynecol Reprod Med. 2009;19(12):344–359.
  • Speroff L, Fritz MA. Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2005:200–214.
  • Kaneshiro B, Edeman A, Carlson N, Nichols M, Jensen J. The relationship between body mass index and unintended pregnancy; results from the 2002 National Survey of Family Growth. Contraception. 2008;77(4):234–238.
  • Pantoja M, Madeiros T, Baccarin MC, Morais SS, Bahamondes L, Fernandes AM. Variations in body mass index of users of depot- medroxyprogesterone acetate as a contraceptive. Contraception. 2010;81(2):107–111.
  • Graesslin O, Korver T. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience. Eur J Contracept Reprod Health Care. 2008;13(Suppl 1):4–12.
  • Kaunitz AM, Darney PD, Ross D, Wolter KD, Speroff L. Subcutaneous DMPA vs intramuscular DMPA: a 2 years study of contraceptive efficacy and bone mineral density. Contraception. 2009;80(1):7–17.
  • Edelman AB, Cherala G, Stancyzk FZ. Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review. Contraception. 2010;82:314–323.
  • Edelman AB, Carlson NE, Cherala G, et al. Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity. Contraception. 2009;80:119–127.
  • Westoff C, Torgal, A, Mayeda E, Pike, M, Stanczyk, F. Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception. 2010;81:474–480.
  • Brunner Huber LR, Toth JL. Obesity and oral contraceptive failure: Findings from the 2002 National Survey of Family Growth. Am J Epidem. 2007;166(11):1306–1311.
  • Holt V, Cushing Haugen K, Daline J. Body weight and risk of oral contraceptive failure. Obstet Gynecol. 2002;99:820–827.
  • Holt V, Scholes D, Wicklund K, Cushing-Haughen K, Daling J. Body mass index, weight and oral contraceptive failure risk. Obstet Gynecol. 2005;105:46–52.
  • Trussel J, Schwarz EB, Guthrie K. Obesity and oral contraceptive pill failure. Contraception. 2009;79(5):334–338.
  • Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data. Fertil Steril. 2002;77(2 Suppl 2):S13–S18.
  • Dieben TO, Roumen FJ, Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol. 2002;100(3):585–593.
  • Westhoff C. Higher body weight does not affect NuvaRing’s efficacy [abstract]. Obstet Gyneco.l 2005;105(Suppl 4):56S.
  • Bjarnadottir RI, Tuppurainen M, Killick SR. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ ethinyl estradiol. Am J Obstet Gynecol. 2002;186(3):389–395.
  • Dinger J, Cronin M, Mohner S, Schnellschmimidt I, Minh T, Westhoff C. Oral contraceptive effectiveness according to body mass index, weight, age and other factors. (EURAS-OC). Am J Obstet Gynecol. 2009;80(1):7–17.
  • Segall-Gutierrez P, Taylor D, Liu X, Stanczyk FZ, Azen S, Mishell DR. Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously. Contraception. 2010;81:487–495.
  • van Hylckama Hlieg A, Helmerhost FM, Rosendall FR. The risk of deep venous thrombosis associated with injectable depot- medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device. Arterioscler Thromb Vasc Biol. 2010;30:2297–2300.
  • Tice JA, Karliner L, Walsh J, Peterson AJ, Feldman MD. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Amer J Med. 2008;121:885–893.
  • Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luektich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232(4):515–529.
  • DeMaria EJ, Sugerman HJ, Kellum JM, Meador JG, Wolfe LG. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg. 2002;235(5):640–645.
  • Hall JC, Watts JM, O’Brien PE, et al. Gastric surgery for morbid obesity. The Adelaide Study. Ann Surg. 1990;211:419–427.
  • Rochester D, Jain A, Polotsky AJ, Polotsky H, Gibbs K, Isaac B, et al. Partial recovery of luteal function after bariatric surgery in obese women. Fertil Steril. 2009;92:1410–1415.
  • Mehri Z. Impact of bariatric surgery on female reproduction. Fertil Steril. 2009;92(5):1501–1508.
  • Gerrits EG, Ceulemans R, van Hee R, Hendrickx L, Totte E. Contraceptive treatment after biliopancreatic diversion needs consensus. Obesity Surg. 2003;13:378–382.
  • Krishnan S, Hacker M, Haider S, et al. Contraceptive counseling and utilization in women who underwent bariatric surgery. Poster presented at Annual Meeting of the Association of Reproductive Health Professionals, October 1, 2009, Los Angeles, CA.
  • Elkins G, Whitfield P, Marcus J, Symmonds R, Rodriguez J, Cook T. Noncompliance with behavioral recommendations following bariatric surgery. Obesity Surg. 2005;15:546–551.
  • Maggard MA, Yermilov I, Li Z, et al. Pregnancy and fertility following bariatric surgery. A systematic review. JAMA. 2008;300(19):2286–2296.
  • Victor A, Odlind V, Kral JG. Oral contraceptive absorption and sex hormone binding globulins in obese women: effects of jejunoileal bypass. Gastroenterol Clin North Am. 1987;16:483–491.
  • American Society for Reproductive Medicine. Obesity and reproduction: an educational bulletin. Practice Committee Birmingham, AL. Fertil Steril. 2008;90(Suppl 3):S21–S29.
  • Merhi ZO. Challenging oral contraception after weight loss by bariatric surgery. Gynecol Obstet Invest. 2007;64:100–102.
  • Viegas M, Vasconselos RS, Neves AP, Diniz ET, Bandeira F. Bariatric surgery and bone metabolism: a systematic review. Arq Bras Endocrinol Metabol. 2010;54(2):158–162.
  • Abdollahi M, Cushman M, Rosendaal FR. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and contraceptive use. Thromb Haemost. 2003;89(3):493–398.
  • Pomp ER, le Cessie S, Rosendaal FE, Doggen CJ. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol. 2007;139:289–296.
  • Gosman G, King W, Schrope B, Steffen K, Strain G, et al. Reproductive health of women electing bariatric surgery. Fertil Steril. 2010;94:1426–1431.
  • Paulen ME, Zapata LB, Cansino C, Curtis KM, Jamieson D. Contraceptive use among women with a history of bariatric surgery: a systematic review. Contraception. 2010;82:86–94.